abstract |
The present invention provides modified neutralizing anti-GDF-8 antibodies which are expressed in host cells to a significantly greater extent than previous anti-GDF-8 antibodies. The invention also provides methods of using a composition comprising such antibodies to increase muscle mass or strength and to treat or prevent a muscle disorder, a neuromuscular disorder, a metabolic disorder, an adipose tissue disorder, or a bone disorder. |